Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

P3 Health Partners Inc. (PIII)

8.86
-0.08
(-0.89%)
At close: April 28 at 4:00:01 PM EDT
Loading Chart for PIII
  • Previous Close 8.94
  • Open 9.04
  • Bid --
  • Ask --
  • Day's Range 8.70 - 9.28
  • 52 Week Range 7.00 - 40.50
  • Volume 2,928
  • Avg. Volume 18,963
  • Market Cap (intraday) 3.501B
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) --
  • EPS (TTM) -54.00
  • Earnings Date May 6, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 16.25

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

p3hp.org

360

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PIII

View More

Performance Overview: PIII

Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PIII
21.24%
S&P 500 (^GSPC)
6.00%

1-Year Return

PIII
60.27%
S&P 500 (^GSPC)
8.41%

3-Year Return

PIII
97.15%
S&P 500 (^GSPC)
28.95%

5-Year Return

PIII
98.23%
S&P 500 (^GSPC)
93.08%

Compare To: PIII

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PIII

View More

Valuation Measures

Annual
As of 4/28/2025
  • Market Cap

    28.91M

  • Enterprise Value

    156.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.02

  • Price/Book (mrq)

    0.38

  • Enterprise Value/Revenue

    0.10

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -9.05%

  • Return on Assets (ttm)

    -24.23%

  • Return on Equity (ttm)

    -106.44%

  • Revenue (ttm)

    1.5B

  • Net Income Avi to Common (ttm)

    -135.85M

  • Diluted EPS (ttm)

    -54.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    38.82M

  • Total Debt/Equity (mrq)

    112.79%

  • Levered Free Cash Flow (ttm)

    -4.59M

Research Analysis: PIII

View More

Company Insights: PIII

Research Reports: PIII

View More

People Also Watch